Atlas Trials

Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue

Clinical trial NCT03120637 · COMPLETED

Trial details

NCT number
NCT03120637
Sponsor
Institute of Liver and Biliary Sciences, India
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Septic ShockVasoplegiaCirrhosis, LiverRefractory Shock
Start date
2017-01-01
Primary completion
2018-01-10
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.